Procter & Gamble reports 4% organic sales growth in Q1 FY2027 and keeps FY27 outlook amid cost headwinds

Procter & Gamble announced that first‑quarter fiscal 2027 organic sales rose 4.0% year‑over‑year, driven by volume, pricing and mix. Core earnings per share were $2.00, up 1% on a reported basis. The company reaffirmed its full‑year FY27 guidance of 1%‑3% organic sales growth and core EPS growth of 0%‑3% (or $6.89‑$7.11 per share), while flagging an after‑tax cost headwind of roughly $1.4 billion.

The maintained guidance signals that earnings expectations for FY27 remain unchanged, but the disclosed $1.4 billion cost headwind could compress margins and reduce cash flow, affecting dividend and buyback capacity. Investors will watch whether productivity gains offset the higher commodity and energy costs.

  • 1Organic sales grew 4.0% year‑over‑year on a reported basis.
  • 2Core earnings per share were $2.00, up 1% on a reported basis.
  • 3Full‑year FY27 guidance calls for organic sales growth of 1%‑3% (reported basis).
  • 4Full‑year FY27 core EPS guidance is growth of 0%‑3%, equating to $6.89‑$7.11 per share (reported basis).
  • 5The company expects an after‑tax cost headwind of approximately $1.4 billion from higher raw‑material, energy and transportation costs.
  • 6Free cash flow productivity for the quarter was 93% (reported basis).
  • Some materials (11) cite a $1.9 billion after‑tax cost headwind, while others (4,6,9) cite $1.4 billion.

Sources